Presently, there is no cure or effective treatment for spinal cord injury (SCI). Studies in SCI patients have shown that for a treatment to be effective it must primarily improve their quality of life. Numerous studies have shown that stem cells represent an alternative treatment for various disorders and have shown promise in several disease/trauma states. For instance, the use of autologous CD34 + stem cells has been shown to ameliorate symptoms of several disorders such as leukemia, cardiomyopathy, diabetes, and several autoimmune diseases, including multiple sclerosis. For the first time, we report eight case studies of SCI (four acute, four chronic) with approximately 2 years of follow-up that were administered bone marrow stem cells (BMSCs) via multiple routes: directly into the spinal cord, directly into the spinal canal, and intravenous. Magnetic resonance imaging illustrated morphological changes in the spinal cord of some of the patients following BMSCs administration. Comprehensive evaluations demonstrate improvements in ASIA, Barthel (quality of life), Frankel, and Ashworth scoring. Moreover, in order to assess bladder function, we designed a simple numerical clinical scoring system that demonstrates significant changes in bladder function following BMSCs administration. To date, we have administration BMSCs into 52 patients with SCI and have had no tumor formations, no cases of infection or increased pain, and few instances of minor adverse events. These studies demonstrate that BMSCs administration via multiple routes is feasible, safe, and may improve the quality of life for patients living with SCI.
INTRODUCTION
strategies (23, 35, 46) . Scientists are compelled to find a cure or effective treatment for SCI; however, the heterogeneity of human SCI represents an enormous challenge Spinal cord injury (SCI) is a devastating disorder afflicting millions across the world (18) . Presently, there for finding a standard of care. With our present technology, realistically the SCI community would greatly ben-is no cure or effective standard of care for SCI. Many treatments have been tested in clinical trials, including efit with a treatment that promotes partial functional recovery leading to an improved quality of life (2, 3) . the use of methylprednisolone (9, 10) , GM1 ganglioside (24) , decompression (51) , and 4-aminopyridine (14), all Stem cells have been identified in various adult organs where they are thought to contribute to tissue re-of which have only produced marginal benefits with adverse side effects. The present standard of care for SCI pair. The expanding field of adult stem cell research has demonstrated numerous results concerning the broad is methylprednisolone and/or decompression. However, neither of these treatments has prevented the pathologi-differentiation potential of adult stem cells. Compared to embryonic stem cells, adult tissue-specific stem cells cal cascade triggered by SCI and the efficacy of methylprednisolone is questionable (29) .
have a limited self-renewal ability and plasticity, but yet they have been proven to be multipotent. For example, Tissue loss from primary trauma to the spinal cord and the complexity of cell types required for functional neural stem cells were found to repopulate the hematopoietic system (5) , as well as differentiate into all three recovery exemplifies a need for cellular replacement germ layers (16) . Furthermore, bone marrow cells (MAPCs) nosuppressants within the last month; no multiple acute injuries; no active pressure ulcers of the skin, especially were shown to generate neuronal phenotypes as well as endoderm (32) , while muscle-derived stem cells have in the iliac crest region; no patients that cannot follow a strict physical therapy regimen; no obesity; and no pa-been shown to express neural markers (1) . These results demonstrated the feasibility of using different adult stem tients with a life expectancy of less than 2 years. Following admittance into the study patients underwent an ex-cell populations for autologous therapeutic applications in animal models. Many cell-based strategies have been tensive medical evaluation, including magnetic resonance imaging, psychological examination, and neurological successful in SCI animal models, but when clinically translated to the human condition they have all produced examination by physicians trained with the Frankel scale and American Spinal Injury Association (ASIA) impair-little or no effect (49) .
Numerous studies have shown that CD34 + stem cells ment scale. Patients were also evaluated using the Ashworth scale (spasticity), Barthel Index (quality of life), (HSCs) represent an alternative treatment for various disorders in humans. For instance, the use of autologous and a newly developed bladder function scale designated the Geffner, Gonzalez, Santacruz, and Flor (GGSF) CD34 + stem cells has been shown to ameliorate symptoms of several disorders, such as leukemia (4), cardio-Bladder Function Scale. All patients underwent standard physical therapy prior to and after transplantation. Pa-myopathy (37), diabetes (45, 52) , and several autoimmune diseases, including multiple sclerosis (20) . This demon-tients were classified into acute or chronic injury according to the International Campaign for Cures of spinal strates the heterogeneous potential that CD34 + stem cells have for clinical applications.
cord injury Paralysis (ICCP) guidelines (chronic injuries are defined as patients who have been injured longer Based on the inadequate standard of care for SCI, we sought to develop a rigorous clinical transplantation than 1 year where the preceding 6 months there were no changes in functional capacity) (21) . All acute patients program. The objective of this study was to demonstrate that multiple route administration of bone marrow stem were not treated with any other medications prior to BMSCs transplantation. cells (BMSCs) for SCI is safe and feasible. In addition, administration with BMSCs via multiple routes: directly Isolation of Autologous Bone Marrow Cells into the spinal cord, directly into the spinal canal, and for Administration intravenous improves the quality of life for SCI patients. This novel multiroute technique of BMSCs administra-Bone marrow was harvested by aspiration at a minimal number of sites under intrathecal or no anesthesia tion may be an ideal method to assure that the cells reach their necessary target in order to promote repair.
depending on the individual case. Bone marrow (100 ml) was harvested using only one skin puncture site on Using this technique, we have had no cases of tumor formation, infection, or increased pain, and few instances the right and left sides. A multiholed needle was introduced into the iliac bone between both posterior iliac of minor adverse events. spines; 5-ml aspirations were collected at a time for a MATERIALS AND METHODS total of 10 aspirations on the left and 10 aspirations on Patients Guidelines the right. The bone marrow was placed in a blood collecting bag with 15,000 units of sodium heparin and All studies were approved in accordance with the ethical committee of Luis Vernaza Hospital, Guayaquil, Ec-kept on ice. Using a satellite bag system and centrifugation at 1500 rpm for 20 min, we obtained the buffy coat. uador. Acute and chronic patients with spinal cord injuries were enrolled in this study and an informed consent
The buffy coat was transferred into a bag containing 75 ml of ficol-hypaque with 5000 units of heparin and cen-was obtained from each patient. All patients were evaluated prior to enrollment in this study. Some of the in-trifuged at 1000 rpm for 30 min. The supernatant, which contains the mononuclear cells, was then washed with clusion criteria were: have a spinal cord injury with paraplegia or paraparesia; not have any impediments to sterile saline solution and placed into a blood collecting bag and a sample was processed for FACS analysis to effect the analysis of the spinal cord with magnetic resonance imaging; be over the age of 13 with consent of obtain CD34 + /CD45 − cell counts. The mononuclear cells were resuspended in saline and autologous plasma for a the responsible adult if under 18; have a desire and be motivated to participate in the study; and have an abso-total volume of 80 ml. The average total of mononuclear cells obtained for transplantation was 4 × 10 8 cells. lute understanding of the informed consent. Some of the exclusion criteria were: doubting that you can follow the Within that administration population there was an average of 90 × 10 6 CD34 + cells. The administration quantity specific study outlined; depression, psychosis, or any other mental disorders; no alcohol or drug abuse; other was based upon preclinical work on SCI animal models (35) and human autologous stem cell transplantation into diseases, especially those with blood-related disorders; no active infections; no patients who have taken immu-cardiac myopathies (6, 41, 42) .
Identification of Cells by Fluorescence Activated
tion with definitions as follows: 0 = no increase in tone, 1 = slight increase in muscle tone, manifested by a catch Cell Sorting (FACS) and release or minimal resistance at the end of the ROM FACS analysis was performed using the FACS Caliwhen the affected part(s) is moved in flexion or extension, bur from Becton, Dickinson (BD) (Franklin Lakes, NJ). 1+ = slight increase in muscle tone, manifested by a The ISHAGE method was used for obtaining CD34 + cell catch, followed by minimal resistance throughout the recounts as previously described (25) . Briefly, samples mainder (less than half) of the ROM, 2 = more marked were incubated with CD34 and CD45 monoclonal antiincrease in muscle tone through most of the ROM, but bodies followed by Pharm Lyse Lysing solution, affected part(s) easily moved, 3 = considerable increase in TruCount Tubes, and Via Probe (7-AAD) (all from BD). muscle tone, passive movement difficult, and 4 = affected The acquisition and analysis of data was composed uspart(s) rigid in flexion or extension. We evaluated these ing Cell Quest software (BD). Prior to data acquisition, three clinical parameters because they are widely accepted a gate was established to exclude CD34 − , CD45 − events assessment methods used in SCI and we are not equipped in order to eliminate any debris that may contaminate to perform somatosensory evoked potentials or motor the sample. evoked potentials.
Administration of Bone Marrow Stem Cells
Quality of Life Evaluation and Bladder All patients were administered with BMSCs using the Function Evaluation same paradigm. Under general anesthesia we perform a
The Barthel Index (www.strokecenter.org) was used radioscopic assessment of the vertebral injury area.
in order to document changes in quality of life following After careful evaluation of the injury site, a laminectoadministration of BMSCs. Briefly, there are 10 categomy(s) was performed in order to expose the spinal cord.
ries [feeding (0, 5, 10), bathing (0, 5), grooming (0, 5), Following clear visibility of the spinal cord, we carefully dressing 0, 5, 10), bowels (0, 5, 10), bladder (0, 5, 10), removed the scar tissue and detethered the cord. Using toilet use (0, 5, 10), transfers-bed to chair and back (0, a 21-gauge needle attached to a syringe, multiple micro-5, 10, 15), mobility-on level surfaces (0, 5, 10, 15), punctures were then performed and 1 ml of cell suspenand stairs (0, 5, 10)] for a maximum score of 100. After sion was injected into multiple locations in and around carefully evaluating bladder function with ultrasounds the injury epicenter and into any intraspinal cavities for of the kidneys, ureters, and bladder (we were unable to a total of 20 ml. The dura was then sutured shut and perform urodynamic studies) we noticed a need for a another 30 ml of the cell suspension was administered simplified in-depth scoring system that takes into acinto the spinal canal. The remaining 30 ml was adminiscount the method of voiding following SCI. We designed tered intravenous for a total of 80 ml of cell suspension.
the Geffner, Gonzalez, Santacruz, and Flor (GGSF) scale, We used a multiple route administration delivery system which is a bladder function scoring system from 0 to 6. in order to assure that the BMSCs reach their appro-A score of 0 = no urinary bladder sensation or function, priate target. It has been previously shown that intrave-1 = patients with cystostomies that when are closed may nous administration of BMSCs had little to no effect on involuntarily void through the urethra, 2 = bladder sen-SCI patients (48) . sation or autonomic symptoms and inability to void, 3 = Neurological Evaluation bladder sensation or autonomic symptoms and passive voiding (spontaneous release of urine), 3.5 = patients Following acceptance into the study all patients underwent an initial evaluation that consisted of the use of the with open cystostomies that have bladder sensation or autonomic symptoms and passively void through the ASIA, Frankel, and Ashworth scales (Tables 1 and 2). Follow-up testing was done at approximately 6 months, 1 urethra (spontaneous release of urine), 4 = bladder sensation with incomplete voiding (needs catheterization to and 2 years after administration except in a few cases indicated so ( Table 3 ). All neurologists involved did not complete voiding), 5 = bladder sensation with active ability to void; however no control while voiding, 6 = participate in any recruitment for the study. The ASIA scale was used to evaluate motor and sensory function as complete bladder control. Definitions are listed in Table  5 , and the scoring sheet is listed in Table 4 . previously described (48) . The Frankel score was also used to classify each SCI patient with definitions as fol-Magnetic Resonance Imaging (MRI) lows: A = complete paralysis, B = sensory function only below the injury level, C = incomplete motor function be-For all MRI studies a General Electric 1.0 Tesla closed system was used. In order to determine the site low injury level, D = fair to good motor function below injury level, and E = normal function. The widely used of injury, we analyzed several T1 and T2-weighted images as previously described (22) . Prior to acceptance and accepted modified Ashworth score (34) was used in order to measure spasticity changes following transplanta-into the study, patients underwent MRI and only patients 
A summary of neurological evaluations for eight case studies. ND indicates not done. Case 4, 5, 6, 7, and 8 can walk with the aid of a walker or other medical device. There were few changes in spasticity (Ashworth score) for all cases described. The criteria of scoring systems are described below. *1 year 6 months. †1 year 3 months.
ASIA Impairment Scale
A complete: no preservation of function below level of injury, and no sacral sparing (S4-S5) B incomplete: sensory but no motor function is preserved below the neurological level and includes the sacral segments S4-S5 C incomplete: motor function is preserved below the neurological level, and more than half of key muscles below the neurological level have a muscle grade less than 3 D incomplete: motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a grade of 3 or more E normal: motor and sensory function are normal Frankel Scale A complete paralysis B sensory function only below the injury level C incomplete motor function below injury level D fair to good motor function below injury level E normal function Modified Ashworth 0 no increase in tone 1 slight increase in muscle tone, manifested by a catch and release or minimal resistance at the end of the ROM when the affected part(s) is moved in flexion or extension 1+ slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM 2 more marked increase in muscle tone through most of the ROM, but affected part(s) easily moved 3 considerable increase in muscle tone, passive movement difficult 4 affected part(s) rigid in flexion or extension with clear midsagittal T2-weighted images of the lesion an average total of 90.0 × 10 6 CD34 + cells per administration (Table 3 ). Prior to BMSCs administration each site were allow into the study. The lesion site was quantified according to the midsagittal T2-weighted image patient underwent an MRI and neurological examination. At approximately 6 months, 1 year, and 2 years and the vertebral segments were identified in order to isolate the area of interest for administration of BMSCs.
following BMSCs administration the patients all underwent follow-up MRIs and neurological exams. Following administration of BMSCs there are noticeable mor-
RESULTS
phological changes within the spinal cord as illustrated by sequential MRIs of an acute patient ( Fig. 2a-d) and Table 3 illustrates the demographics of each case (Cases 1-4 acute; Cases 5-8 chronic). Bone marrow chronic patient ( Fig. 2e -h) taken prior to administration, 6 months after BMSCs administration, 1 year after isolated from each patient was evaluated by FACS analysis for the presence of CD34 + stem cells ( Fig. 1 
, Table
BMSCs administration, and approximately 2 years after BMSCs administration (Fig. 2 ). These studies illustrate 3). The patients were administered with an average of 1.2 × 10 6 CD34 + cells per kilogram of body weight for that administration of BMSCs directly into the spinal Table 2 , Fig. 3a -c).
Comprehensive data analysis indicates an initial Barthel A 28-year-old male sustained a gunshot wound to the T9 vertebral body resulting in a lesion and contusion scoring of 20 ( Fig. 4a ), Ashworth 0 (Table 1) , and bladder function (GGSF) score of 0 ( Fig. 5a ). Forty days injury with metallic fragment in the spinal canal. Initial evaluation of the patient's MRI illustrated a lateral hemi-postinjury the patient had the bullet removed and was administered BMSCs. MRI of the vertebral column ap-section of the spinal cord at T9.1-T9.2 resulting from the bullet. In addition there was a contusion at the T8.1-proximately 2 years following administration illustrated the continual existence of the lateral hemisection with T10.1 levels with edema and spinal cord thickening ( Fig. 2a ). The patient's evaluation prior to BMSCs ad-residual cavities formed from T7.1 to T9.1 and spinal cord thickening ( Fig. 2d ). In addition, there appeared to ministration demonstrates that he sustained a complete injury (ASIA impairment grade A, motor score 50, Fran-be the formation of a small bridge of tissue with the . 4a ). Her most recent 4a) and bladder function improved from no function to complete bladder control (Fig. 5a ). The patient can stand MRI (18 months) illustrated the persistence of a complete transection at T5.2-T6.1 with scar tissue at T5.2-on parallel bars and takes small strides with the use of a walker or crutches. Interestingly, the patient now T6.1. In addition, there was retraction of supraposterior cord fibers. There was no evidence of edema. At 18 comes to physical therapy riding a quad motor bike. months following BMSCs administration, her bladder Case 2 function has improved from none to having sensation (Fig. 5a ). Also, she improved from an ASIA impairment A 33-year-old female sustained a gunshot wound to the thoracic area resulting in an injury to the spinal cord grade A to C (52, 54, and 57 for motor, sensory light touch, and sensory pinprick, respectively), Frankel A to at the T4 vertebral level. Initial evaluation of the patient's MRI illustrated a transection at T5.2-T6.1 and a C, and her spasticity had decreased from a 3 to 2 (Tables  1 and 2 , Fig. 3a-c ). There was no sensation below the severe contusion injury with edema from T4.3 to T5.1. The patient's evaluation prior to BMSCs administration T9 dermatome. Overall, we have noticed a qualitative increase in her life. She can now stand on the parallels demonstrated that she sustained a complete injury (ASIA impairment grade A, motor score 50, Frankel grade A) with braces on. with no motor functions preserved below the level of Case 3 injury. In addition, there was no sensation (light touch or pinprick; score of 47, 47, respectively) below the T7 A 28-year-old male fell from a tree approximately 8 m and sustained an injury to his spinal cord at the T5-6 dermatome (Tables 1 and 2, Fig. 3a-c) . Eleven days following her SCI, the patient underwent a first surgery in vertebral spinal level. Initial MRI illustrates an oblique hemisection on the left side at T5.1-T6.1 and contusion order to decompress the spinal cord and remove the bullet fragment from the spinal canal. Following decom-with edema cranial at T4.3-T3.1 and caudal at T6.2-T7.3. There is dilation of the ependyma below the injury pression, the patient had no functional changes even and posterior vertebral displacement narrowing the ca-below the injury area (motor score 50) (Tables 1 and 2 , Fig. 3a-c ). In addition, there was no sensation (light nal. Initial neurological evaluation demonstrates that the patient sustained a complete injury (ASIA impairment touch or pinprick; score of 42, 42, respectively) below the T5 dermatome ( Table 2 , Fig. 3b, c) . Patient was ad-grade A, Frankel A) with no motor function preserved No urinary bladder sensation or function* † ‡ §
1.
Patients with cystostomies that when are closed may involuntarily void through the urethra* 2.
Bladder sensation or autonomic symptoms and inability to void* † ‡ § 3.
Bladder sensation or autonomic symptoms and passive voiding (spontaneous release of urine)* † ‡ 3.5. Patients with open cystostomies that have bladder sensation or autonomic symptoms and passively void through the urethra (spontaneous release of urine)* 4.
Bladder sensation with incomplete voiding (needs catheterization to complete voiding) † ‡ § 5.
Bladder sensation with active ability to void; however no control while voiding 6.
Complete bladder control *Patients use suprapubic cystostomies in order to void their urinary bladder. †Patients use a catheter in order to void their urinary bladder. ‡Patients with a urine collector. §Patients that manually compress (massage) the hypogastric region in order to void their urinary bladder.
ministered BMSCs 13 days following SCI and metal and passive voiding (spontaneous release of urine) ( Fig.  5a ). We were unable to perform additional MRIs after rods were placed in order to stabilize his vertebral column. The patient never showed up for his rehabilitation placement of the metal rods. Considering the challenges presented with his bed sore and the fact that he has not regimen and was given inadequate care at home immobile for 32 days. The patient acquired a giant bed sore performed any rehabilitation regimen, this patient has improved his quality of life following administration of that had to be surgically removed. The bed sore caused an infection, leading to a definitive colostomy and re-BMSCs. moval of the left femoral head. Due to the severe bed Case 4 sore the patient had many autologous skin graft surgeries in order to repair the damaged area. The patient had A 31-year-old male fell from a ladder approximately 3 m and sustained an injury to his spinal cord at the an initial Barthel score of 5 (Fig. 4a ), bladder function score of 0 (Fig. 5a ), and Ashworth (spasticity) score of T12-L1 vertebral level. The patient was evaluated immediately after injury. MRI of the vertebral column il-0 (Table 1) . At approximately 2 years post-BMSCs administration the patient has an improved Frankel grade lustrated posterior vertebral displacement of L1 over T12 grade II and severe narrowing of the spinal canal. of C, an ASIA impairment grade of A with some improvements in his sensory score (60, 64 for light touch There was a contusion with edema at T12.2-L1.3 with a hematoma. The initial neurological evaluation demon-and pin prick, respectively), and no sensation below the T11 dermatome (Tables 1 and 2 , Fig. 3b, c) . His quality strates that the patient sustained a complete injury (ASIA impairment grade A, Frankel A) with no motor of life score (Barthel Index) has increased from 5 to 40 ( Fig. 4a) and bladder function increased from no bladder function preserved below the injury level (motor score 50) (Tables 1 and 2 , Fig. 3a ). There was no sensation function to bladder sensation or autonomic symptoms Table 5 
. Definitions and Terms
Bladder sensation: A feeling or awareness of conditions within the urinary bladder resulting from the stimulation of sensory receptors Bladder function: The action performed by the urinary bladder (i.e., the ability to void urine) Suprapubic cystostomies: A connection between the urinary bladder and the skin to drain urine from the bladder Void: The ability to evacuate (empty) the urinary bladder Involuntary: Independent of or contrary to volition Dysesthesia: Abnormal sensations on the skin, such as a feeling of numbness, tingling, burning, itching, electric shock, pins and needles Autonomic symptoms: Dysesthesia, pyloric erection, pain, burning, sudden hypertension, sweating, and bradycardia normally triggered by distention of the urinary bladder Passive voiding: Evacuation or partial evacuation of the urinary bladder without any control Manuel bladder (hypogastric) compression for voiding: Through active compression (massage) of the hypogastric region, urine is released through the urethra (light touch or pinprick; score of 76 and 76, respec-kel score C) with active movement against gravity at the hip flexors and sensation through the L1 dermatome and tively) below the T12 dermatome ( Table 2 , Fig. 3b, c) and he had an initial Ashworth score of 0 (Table 1) .
at the S2-S3 dermatome (light touch and pin prick; 84 and 80, respectively) (Tables 1 and 2, Fig. 3a-c) . Bar-Quality of life scoring demonstrates an initial Barthel score of 30 ( Fig. 4a ) and no bladder function (Fig. 5a) .
thel scoring demonstrates an improvement from an initial score of 30 to 90 (Fig. 4a ) while bladder function Five days following initial trauma posterior rods were placed in order to stabilize the vertebral column and ad-went from absolutely no function to bladder sensation with active ability to void; however, no control while ministration of BMSCs was done. At 2 years following BMSCs administration the patient has improved signifi-voiding (Fig. 5a ). We were unable to do any more MRI due to the placement of metal rods. This patient can cantly (ASIA impairment grade C, motor score 58, Fran-walk a couple of blocks with the use of a walker and lowing injury. MRI prior to BMSCs administration illustrated an anterior disc herniation at T11-12 and a lateral ankle braces.
hemisection of the spinal cord at T11.3. In addition, Case 5
there was a residual cavity from T12.1 to T12.2 (Fig.  2e) . The initial neurological evaluation demonstrated A 37-year-old male sustained an injury to the spinal cord at the T12 vertebral spinal level from a car acci-that the patient sustained an incomplete injury (ASIA impairment grade B, Frankel C) with only palpable or dent. The patient was evaluated 6 years 2 months fol- Figure 5 . Evaluation of bladder function using a newly designed bladder function assessment scoring system entitled Geffner, Gonzalez, Santacruz, and Flor (GGSF) Bladder Function Score. There were significant improvements in bladder function for acute SCI Cases 1 and 4 (a) and chronic SCI Case 7 (b) after administration of BMSCs. In addition, chronic SCI Cases 5 and 6 improved to complete bladder control. Overall, all SCI cases evaluated had an improvement in bladder function as assessed using the GGSF scale. Full scale descriptions are attached as an appendix. ND. not done. **The last follow-up for Case 2 was at 1 year 6 months. The last followup for Case 7 was at 1 year 3 months. visible contractions at the L2 level (ASIA motor score 94, and Frankel D grade (Tables 1 and 2, Fig. 3a ). Moreover, his sensory scoring has improved from a 66 light 52, 1 point on each side at the L2 level) (Tables 1 and  2 , Fig. 3a ). In addition, there was impaired sensation touch/66 pin prick to a 94 light touch/94 pin prick ( Table 2 , Fig. 3b, c) . Barthel score has improved dramati-(light touch or pinprick; score of 88 and 88, respectively) through the S4-5 dermatome ( Table 2 , Fig. 3b , cally to a maximum score of 100 and he has complete bladder function (Figs. 4b and 5b, respectively) . He now c) and an Ashworth score of 1 (Table 1 ). Initial Barthel score was a 65 (Fig. 4b) and he had bladder sensation has the ability to walk using forearm crutches and is able to walk up and down stairs. with active ability to void; however, no control while voiding (GGSF score of 5) (Fig. 5b) . Six years and 3
Case 7 months following SCI the patient underwent a partial discectomy and administration of BMSCs. At 2 years A 27-year-old male sustained a gunshot wound to the scapula region that passed through his spine and exited following administration the patient has improved significantly with the MRI illustrating a disc herniation at his chest, causing a spinal cord injury at the T11 vertebral level. The patient was evaluated for BMSCs admin-T11-12, a lesion at T11.3, and a small cavity at T12.1 (Fig. 2h ). His neurological evaluation demonstrates an istration 5 years 9 months follow SCI. Initial MRI illustrated a fracture at T11.1 with a cavity from the ASIA impairment grade of C (improved motor score of 68, scores of 1-3 from the L2-S1 level), and Frankel D projectile in the vertebral body and an oblique hemisection of the spinal cord at T11.1-T11.2 His neurological (Tables 1 and 2, Fig. 3a ). His ASIA sensory score has increased from 88 light touch and 88 pin prick to 100 evaluation prior to BMSCs administration demonstrated that he has an complete injury (ASIA impairment grade light touch and 101 pin prick ( Table 2 , Fig. 3c, b ). Barthel score is now 100 (maximum value) and he has full A, Frankel A) with a motor score of 50, meaning the absence of all key muscles below the injury level (Ta-control of his bladder (Figs. 4b and 5b , respectively). This patient can now walk with braces and crutches for bles 1 and 2, Fig. 3a ). There was no sensation below the T11 dermatome (70 and 70 for light touch and pin prick, more than 1 h. respectively) and his Ashworth score was 0 (Tables 1  Case 6 and 2, Fig. 3b, c) . His Barthel score was 35 and he had no bladder function ( Figs. 4b and 5b , respectively). MRI A 42-year-old male sustained a gunshot wound to the chest in 1984 that penetrated his vertebral column and evaluation 1 year 3 months following BMSCs administration illustrated the existence of the fracture at T11.1 was lodged in his dura at the T4 vertebral spinal level, causing an injury to his spinal cord. The patient immedi-and the oblique hemisection injury has expanded from T11.1-T12.1. There was a small residual cavity above ately underwent a laminectomy at T3-4 and surgical removal of the bullet. MRI prior to BMSCs administration the injury from T10.1-T10.3. Although his MRI demonstrates an expanded injury, his neurological evaluation illustrated that he has an oblique lesion at T3.2-T4.1 and hypoplasia. There is a residual cavity at T3.2-T4.2.
indicated a significant functional improvement (ASIA impairment grade C, improved motor score of 61) (Ta-His neurological evaluation prior to administration (21 years 10 months after initial trauma) demonstrated that bles 1 and 2, Fig. 3a ). In addition, his sensory score has increased slightly with impaired sensation at the S2-S3 he is categorized as an incomplete injury (ASIA impairment grade C, Frankel D) with active movement, gravity dermatome level (light touch 72, pin prick 73) ( Table 2 , Fig. 3b, c) . There are little changes in his spasticity. Bar-eliminated through the L4 level on the left/L3 level on the right and palpable or visible contractions at the thel scoring indicates a significantly improvement to a score of 85 ( Fig. 4b ) and his bladder function has im-L5-S1 level on the left side only (ASIA motor score 62) (Tables 1 and 2, Fig. 3a ). In addition, there was proved from 0 to a 3 (sensation or autonomic symptoms and passive voiding) ( Fig. 5b) . One year 3 months fol-no sensation below the T7 dermatome on the right and impaired through the S4-5 dermatome from T6 (light lowing BMSCs administration with the aid of a walker and braces, this patient has gained the ability to walk. touch or pinprick; score of 66 and 66, respectively) (Table 2, Fig. 3b, c) . Initial Barthel score was 55 (Fig. 4b ) Case 8 and he had bladder sensation with active ability to void; however, no control while voiding (score of 5) (Fig. 5b) .
In 1999, a 44-year-old male fell 8 m and sustained an injury to the spinal cord at the T12 vertebral spinal His 2-year follow-up MRI illustrated minor changes with an oblique lesion at T3.3-T4.3 and hypoplasia.
level. Five days following SCI the patient had metal rods placed in order to stabilize his vertebral column, There remains the residual cavity at T3.2-T4.2. Neurological evaluation 2 years after BMSCs administration which were subsequently removed 4.5 years later. The patient was evaluated at the hospital for BMSCs admin-demonstrated a significant improvement of motor function with an ASIA impairment grade of D, motor score istration in early 2006. His MRI prior to BMSCs admin-istration illustrated a compression of the vertebral body BMSCs via multiple routes is feasible, safe, and most importantly improves the quality of life for both acute at T12 with a 10% posterior displacement. There was compression of the spinal cord at T11.2-T12.1 with a and chronic patients suffering from SCI. Moreover, there has been no incidence of infection or severe ad-residual cavity at T11.2-T12.3. His initial neurological examination with us indicated that he had an incomplete verse reactions for any cases documented to date. This study clearly documents the feasibility of cell replace-injury (ASIA impairment grade C, Frankel C) with active movement, gravity eliminated at L2 and L3 (motor ment strategies as an alternative therapy for SCI. In addition, we have a unique method of delivering the cells; score 58) (Tables 1 and 2, Fig. 3a ). There was no sensation below the L3 dermatome (86 and 86, light touch all patients get cells directly into the spinal cord, directly into the spinal canal, and an intravenous injection of and pin prick, respectively) and his Ashworth score was 2 (Tables 1 and 2, Fig. 3b, c) . His Barthel score was a 55 cells. Although multiple route administration limits the mechanistic understanding for cell-based applications, (Fig. 4b) and he had bladder sensation with incomplete voiding (score of 4) (Fig. 5b) . Two years following this assures us that the BMSCs will reach the necessary target in order to fulfill their niche and possibly promote BMSCs administration his MRI demonstrated a lesion at T11.3-T12.1 with a residual cavity that has shrunk at host endogenous repair within the SCI area. Shi et al. demonstrated that bone marrow-derived CD34 + EPCs T11.2-T11.3. There was a small edema below the lesion at T12.2-T12.3. Neurological evaluation indicated func-from canines migrated to the vascular injury site (44) .
In another study, autologous bone marrow CD34 + cells tional improvement (ASIA C, improved motor score of 70, and Frankel D) and a reduction in spasticity (Tables labeled with magnetic nanoparticles that were delivered into the spinal cord via lumbar puncture migrated into 1 and 2, Fig. 3a ). There was impaired sensation through the S4-5 dermatome with an improved sensory score of the injured site in patients with chronic SCI (13).
Following primary trauma to the adult spinal cord 98 and 98 for light touch and pin prick, respectively ( Table 2, Fig 3b, c) . Barthel scoring indicates he has there is evidence of hemorrhage and blood flow is attenuated within the spinal cord. This disruption in blood improved to the maximum score of 100 ( Fig. 4b) and he has the ability to actively void his bladder (GGSF score flow leads to spinal cord infarction, the disruption of the blood-spinal cord injury barrier, edema, the release of 5) (Fig. 5b) . Interestingly, even though he has the ability to walk with crutches and can go up and down stairs;
vasoactive molecules influencing spinal cord perfusion, and ischemia. This primary disruption ultimately leads because he has active movement against full resistance (score 5) in only 40% of his key muscles he continues to the death of millions of cells and the activation of secondary degeneration, which is a cascade of events to be considered ASIA impairment grade C. that exacerbate primary trauma (18, 36, 38) . Secondary DISCUSSION degeneration is the present target for pharmaceutical intervention in acute SCI; however, any intervention The standard of care for acute SCI is methylprednisolone and/or decompression. Clinical studies using surgi-would have to be applied rapidly as within 72 h the white matter in the spinal cord is thought to be irrevers-cal intervention for acute SCI (decompression) have shown no difference in neurological recovery between ibly damaged (8) and cell death progresses for months due to the complicated cascade of secondary degenera-operated and nonoperated patients (50, 51) . In three National Acute Spinal Cord Injury Studies (NASCIS I, II, tion (19). Autologous stem cells represent an alternative ther-and III), the use of methylprednisolone demonstrated minimal overall benefits (10) (11) (12) . These benefits did not apy when conventional methods have not worked for various devastating disorders. Specifically, CD34 + stem come without much skepticism of the post hoc analysis of the data (17, 30, 40) . Indeed, the use of methylprednis-cells (HSCs) and/or endothelial progenitor cells (EPCs), which are easily attainable from bone marrow or periph-olone or any steroid does not come without risk. In all three NASCIS studies the incidence of sepsis and pneu-eral blood. HSCs and EPCs are well known for their ability to promote angiogenesis (43,54). Angiogenesis is monia was higher in the methylprednisolone groups compared to other treatment groups. Moreover, gastroin-necessary for wound healing and likely plays a critical role in establishing a growth-permissive environment. testinal complications were also reported following high-dose methylprednisolone (10) (11) (12) . According to a Results have shown that EPCs play an essential role in repairing injured blood vessels and transplantation of committee of Canadian physicians, the use of high-dose methylprednisolone is not an evidence-based standard of EPCs into ischemic limbs of rats induced collateral vessel formation (31) . Moreover, it was noted that trans-care for SCI (29) .
It has been demonstrated that intravenous and intra-planted EPCs secrete proangiogenic growth factors such as VEGF, HGF, and IGF-1, which lead to new vessel arterial transplantation of mononuclear cells into SCI is safe (48) . Here we demonstrate that administration of development (39,53). Studies indicate that progenitor cells contribute not only to the restoration of injured tis-ors and knee extensors. This individual can walk with crutches and can go up and down stairs, which is a vast sues, but also to the pathological remodeling (26, 33, 53) . Interestingly, in SCI revascularization occurs prior to improvement in his quality of life. Other challenges are whether to separate out the ASIA upper and lower ex-nerve regeneration (55) . Because BMSCs possess angiogenic properties, we hypothesize that improved blood tremity scores. In almost all of our cases lower extremity scores were nonexistent (total motor score of 50) and a flow and oxygen supply within the injury area may have contributed to the functional improvements seen in SCI 5-10 point increase may make a large difference if one separates the upper and lower extremity scores. In agree-patients transplanted with autologous BMSCs. Alternatively, it is well documented that BMSCs promote host ment with the ICCP panel, our personal observation is that separation of lower and upper extremities in the endogenous repair (15, 27, 28) . For instance, transplantation of marrow stromal cells into SCI rats promotes axo-ASIA motor scale can better indicate functional improvement compared to combining the data, which may nal regeneration (28) , and transplantation of BMSCs into a mouse model of chemically induced pancreatic illustrate a nominal effect (47) . A survey of the SCI community illustrates that one damage causes endogenous pancreatic regeneration (27) . Clearly, administration of autologous BMSCs is a prom-of the most important aspects in improving their quality of life would be the ability to control bladder function ising cell replacement strategy for several human disorders.
(2). This study indicated that presently we would greatly benefit from the development of treatments that lead to One of the greatest challenges in finding a treatment or improving the quality of life for the SCI community partial functional recovery in order to improve the quality of life for the SCI community. Our data clearly dem-is the vast heterogeneity of human SCI; no two injuries are alike. It is well understood that tremendous chal-onstrate that administration of autologous BMSCs improves the quality of life for SCI patients (Figs. 4 and lenges exist in gathering data in order to validate a specific treatment type for SCI (47, 49) . Presently, we have 5). Because bladder function is of great importance, we designed the GGSF bladder function score to facilitate performed administration of autologous BMSCs using our unique multiple route delivery system into 52 SCI bladder function assessment (Tables 4 and 5 ). It is more in depth compared to questionnaires in quality of life patients. However, it has been challenging to gather comprehensive long-term data. Therefore, in this study scoring systems, such as the Barthel index, which are a crude method of assessing bladder function (0 = inconti-we present the eight cases that we have with comprehensive long-term data. We presently have 25 cases of SCI nent, or catheterized and unable to manage alone; 5 = occasional accident; 10 = continent) yet measure overall with slightly greater than 3 months comprehensive follow-up. There have been no cases of tumor formation, quality of life changes. It is well understood that spontaneous recovery in SCI can occur for as long as 1 year increased pain, and/or deterioration of function following administration of BMSCs. There were very few ad-following SCI (21) . Indeed, this may have occurred within our acute SCI patients; however, it is important verse reactions observed following administration of BMSCs. We observed a transient lack of erection and/ to note that all of our acute patients improved significantly with no signs of deterioration or impediment of or ejaculation in four patients, sweating on one half of the body on two patients, and spinal cord canal fistula presumed spontaneous recovery. Moreover, Case 2 had a laminectomy followed by physical therapy for 6 in one patient whose metal rods had to be withdrawn. Nonetheless, there is an overall improvement in the months with no improvements. Following administration of BMSCs, her quality of life improved. quality of life for patients with SCI following administration of BMSCs.
In conclusion, these studies document an alternative cell-based method of treating SCI. Interestingly, it docu-One of the challenges in this study was with patients that had clear improvements that cannot be reflected ments that BMSCs administration via multiple routes may be an effective treatment for patients that suffered correctly by the ASIA impairment grade. There are several individuals that have large improvements in only a SCI from a gunshot wound. To the best of our knowledge this is the first documentation of SCI patients being one to two major muscle groups yielding a definite improvement in quality of life; however, ASIA impairment administered BMSCs directly into the spinal cord following gunshot wounds. Presently, we are investigating grade does not reflect these beneficial changes (7). For instance, Case 8 has gone from an initial ASIA motor long-term effects of BMSCs administration in quadriplegic injuries. However, the difficulties of tracking, score of 58 (motor score of 2 on each side at the L2 and L3 levels) to an ASIA motor score of 70 (motor score monitoring, and assessing several parameters in patients that have been administered BMSCs remains our largest of 5 on each side at the L2 and L3 levels), meaning active movement against full resistance for the hip flex-challenge. Nevertheless, we report here that administra- 
